Of course, the M1-type of TAMs secrete interleukin-1β (IL-1β) and tumor necrosis factor (TNF-α) to promote T cell activation to kill glioma cells, but this effect is minimal in the glioma microenvironment [16]. Here, IL1B is linked to central nervous system cancer.